ISRCTN04517206已完成不适用
A multicentre, parallel group, randomised, double blind study to investigate the efficacy of fluticasone 100 mcg metered dose inhaler (MDI) twice a day (bd) versus placebo MDI bd both via Babyhaler® spacer in 1 to 5 year old children with asthma or asthma-like symptoms during a 6 month study period
GlaxoSmithKline (The Netherlands)0 个研究点目标入组 96 人开始时间: 2005年3月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Children aged 1 to 5 years with recurrent respiratory symptoms for which the GP considered prescribing inhaled corticosteroids
- •2. During the 2-week run-in period, children are eligible if they have symptoms on at least 7 days
排除标准
- •1. Use of oral steroids within 8 weeks prior to the study
- •2. Use of inhaled steroids within 4 weeks prior to the study
- •3. Other respiratory disease
- •4. Inability of parents to fill in diaries
- •5. Incapable of using the inhaler device in a proper way
- •6. Participation in other trials
研究者
相似试验
进行中（未招募）
1 期
Reperfusion thrombolytic therapy for ischemic stroke in patients on the non-vitamin K antagonist oral anticoagulants.EUCTR2020-004898-41-PLMEDICAL UNIVERSITY OF GDANSK300
进行中（未招募）
不适用
A clinical study to assess the efficacy and safety of Oscillococcinum® in the treatment of symptoms of influenza-like illness (ILI), when compared with placebo (a sugar pill without oscillococcinum). The study treatment is given in a randomised, parallel group, double-blind (neither patient or doctor aware of which treatment they have) manner, in several study centres.Systemic and respiratory symptoms of Influenza-like-illness (ILI)MedDRA version: 14.1Level: LLTClassification code 10016797Term: Flu-like symptomsSystem Organ Class: 100000004867EUCTR2013-001869-16-DEBoiron Laboratoires
进行中（未招募）
不适用
A clinical study to assess the efficacy and safety of Octenidine lozenges in the treatment of acute sore throat. Octenedine Lozenges will be compared with an active comparator and against placebo in patients at multiple sites, in a double blind ( patient and doctor) randomised manner.Acute pharyngitisEUCTR2012-002876-15-DECassella-med GmbH & Co KG
进行中（未招募）
不适用
A randomized, multi-center, parallel group, double blind, placebo and formoterol controlled 14 day dose ranging trial of 4 doses of indacaterol delivered via Twisthaler in patients with COPD - NDChronic Obstructive Pulmonary Disease (COPD)MedDRA version: 9.1Level: LLTClassification code 10009026Term: Chronic obstructive airways diseaseEUCTR2007-003189-16-ITOVARTIS FARMA558
进行中（未招募）
1 期
A randomized, multi-center, parallel group, double-blind, placebo and formetrol controlled 14 day dose ranging trial of 4 doses of indacaterol delivered via Twisthaler®, in adult and adolescent patients with persistent asthmapersistent asthmaMedDRA version: 9.1Level: LLTClassification code 10003553Term: AsthmaEUCTR2007-003191-19-SKovartis Pharma Services AG488